… Cardiac sympathetic nerve terminals release … norepinephrine), galanin, and neuropeptide
Y (NPY). Circulating catecholamines predict risk of death in patients with chronic heart failure (…

… Neuropeptide Y has a longer half-life than norepinephrine and potentiates its vasoconstrictor
effect. … The rates of a composite of cardiovascular death or hospitalization for heart failure, …

… and elevated levels of noradrenaline (NA) and cotransmitter neuropeptide Y (NPY). …
Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure…

… of stages 2–5 CKD patients neuropeptide Y robustly predicted cardiovascular events. Such
a … In the current study no patient had congestive heart failure at baseline and appropriate …

… Currently, in the European Society of Cardiology Heart Failure … This is a group of
neuropeptides with widespread distribution in … , while the plasma levels of norepinephrine, renin, …

… of NPY are stored with noradrenaline in sympathetic nerve fibers. NPY … cardiac abnormalities
like hypertension, vascular endothelial cell proliferation, circadian rhythm and heart failure. …

… augments the risk for heart failure in diabetic patients on dialysis [… Neuropeptide Y mediates
cardiac hypertrophy through … response of adult ventricular cardiomyocytes to norepinephrine. …

… Response of plasma neuropeptide Y and noradrenaline to dynamic exercise and ramipril
treatment in patients with congestive heart failure. Clin Physiol. 1994;14:123–34. …

… in hypertension, myocardial infarction, and heart failure. There … role of neuropeptide Y in
cardiovascular health and disease. … to promote cardiac arrhythmia via release of norepinephrine …

… , suggesting the crucial role of ACE2 in balancing the opposite renal effects between ANG II
… of IL-1β increased plasma circulating noradrenaline levels and arterial pressure, suggesting …